In total, a combined group of patients (1958) with diagnoses of ET, PV, PMF, and MPN-U was examined for the presence of JAK2 V617F, JAK2 exon 12, MPL W515L/K, and CALR exon 9 gene mutations. The gene discussed is JAK2; the disease is essential thrombocythemia.